文献速递核素与放射性配体治疗骨显像与常规 SPECT

90钇柠檬酸盐放射性滑膜切除术治疗膝骨关节炎滑膜炎的10年前瞻性观察研究

A prospective observational study on the long-term results of 90Yttrium citrate radiosynoviorthesis of synovitis in osteoarthritis of the knee joint.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-05-25

这项前瞻性观察研究评估了关节腔内注射胶体90钇柠檬酸盐治疗膝骨关节炎患者后10年的应答率,按Kellgren-Lawrence分级分层。早期患者1年优良应答率为82.5%,8年为73.7%,10年降至50%;III级患者优良应答率为45.9%,8年内降至41.2%。结论认为放射性滑膜切除术长期效果良好,应答率取决于Kellgren-Lawrence分期,建议早期进行核素治疗。

要点

  • 早期膝骨关节炎患者放射性滑膜切除术1年优良应答率为82.5%,8年为73.7%。
  • III级患者优良应答率为45.9%,8年内降至41.2%。
  • 应答率取决于Kellgren-Lawrence分期,建议早期行核素治疗。

核心结论

  • 放射性滑膜切除术治疗膝骨关节炎的长期优良应答率较高,且应答率取决于Kellgren-Lawrence分期,建议早期行核素治疗。

研究设计与样本

  • 前瞻性观察研究,对膝骨关节炎患者行关节腔内注射胶体90钇柠檬酸盐治疗,Kellgren-Lawrence I/II级69例,III级72例,随访10年。

主要发现

  • 早期患者疼痛、关节活动度和功能的优良应答率1年为82.5%,8年为73.7%,10年降至50%。
  • III级患者优良应答率为45.9%,8年内降至41.2%。
  • III级患者随访9年和10年时可用患者数从8年的51例显著降至9年的30例和10年的9例,故该组应答率无法评估。

关键数值与推荐

  • 早期患者1年优良应答率82.5%,8年73.7%,10年50%。
  • III级患者优良应答率45.9%,8年内降至41.2%。

临床怎么用

  • 对膝骨关节炎滑膜炎患者,可考虑关节腔内注射90钇柠檬酸盐行放射性滑膜切除术,早期(Kellgren-Lawrence I/II级)患者可能获益更明显。

局限性

  • III级患者9年和10年随访人数显著减少,导致该组远期应答率无法评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Radiosynoviorthesis (RSO) is used for the treatment of inflammatory joint diseases. However, there are no long-term results published comparing it to conservative therapy. Therefore, the aim of this prospective observational study was to evaluate response rates after radionuclide therapy in patients suffering from knee osteoarthritis over a time period of 10 years. METHODS: Radionuclide therapy with intra-articular administration of colloidal 90Yttrium citrate was performed in osteoarthritic patients [Kellgren-Lawrence grades I/II (n = 69) and Kellgren-Lawrence grade III (n = 72)]. RESULTS: In patients with early-stage disease, an excellent/good response with respect to pain, joint mobility, and function was observed in 82.5% for 1 year and in 73.7% for 8 years after therapy. Responses declined to 50% at 10 years post treatment. In grade III patients, an excellent/good response was observed in 45.9%; a decline to 41.2% was observed in the first 8 years. In this group, the number of patients available for follow-up after 9 and 10 years dropped significantly from 51 patients after 8 years to only 30 patients after 9 years, and to nine patients after 10 years. As a result, these response rates were not appraisable. CONCLUSION: Long-term results of radiosynoviorthesis in knee osteoarthritis are excellent/good in many patients. The response rate depends on Kellgren-Lawrence stages, and early-stage radionuclide therapy for osteoarthritis is suggested.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Szentesi M, Nagy Z, Géher P, et al. A prospective observational study on the long-term results of 90Yttrium citrate radiosynoviorthesis of synovitis in osteoarthritis of the knee joint. Eur J Nucl Med Mol Imaging. 2019. PMID: 31129693. doi:10.1007/s00259-019-04350-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。